4//SEC Filing
Kohl Simeon 4
Accession 0001550695-25-000107
CIK 0001550695other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 12:09 PM ET
Size
24.0 KB
Accession
0001550695-25-000107
Insider Transaction Report
Form 4
Kohl Simeon
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−118,419$917,747→ 0 totalExercise: $0.00→ Common Stock (118,419 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−198,320$1,536,980→ 0 totalExercise: $0.00→ Common Stock (198,320 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−91,724$710,861→ 0 totalExercise: $0.00→ Common Stock (91,724 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−105,789$819,865→ 0 totalExercise: $0.00→ Common Stock (105,789 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−198,319$1,536,972→ 0 totalExercise: $0.00→ Common Stock (198,319 underlying) - Disposition to Issuer
Common Stock, par value $0.0001 per share
2025-10-21−619,309→ 0 total - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−41,538$321,920→ 0 totalExercise: $0.00→ Common Stock (41,538 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−25,000$193,750→ 0 totalExercise: $0.00→ Common Stock (25,000 underlying) - Disposition to Issuer
Restricted Stock Units
2025-10-21$7.75/sh−91,724$710,861→ 0 totalExercise: $0.00→ Common Stock (91,724 underlying)
Footnotes (5)
- [F1]Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
- [F2]Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
- [F3]Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
- [F4]All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.
- [F5]Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration.
Documents
Issuer
Performant Healthcare Inc
CIK 0001550695
Entity typeother
Related Parties
1- filerCIK 0001703807
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 12:09 PM ET
- Size
- 24.0 KB